Bianca Rocca: PRECISE-DAPT Score Identifies Bleeding Risk After CABG in Patients With POAF
Bianca Rocca, Editor in Chief at European Heart Journal Cardiovascular Pharmacotherapy, shared on X about a recent article by Mary Rezk et al, published in European Heart Journal – Cardiovascular Pharmacotherapy, adding:
” New in EHJ – CVP
Want something to read during your summer holidays?
Bleeding risk assessment in patients with new-onset atrial fibrillation after coronary surgery: a proof-of-concept study
Is a bleeding risk score able to identify which patients with post-operative AF after CABG are most likely to bleed after discharge?
Guidelines recommend weighing bleeding risk before starting anticoagulation, but none clearly define how to measure it.
The nationwide Swedish registry cohort included 4,436 patients with POAF after first-time isolated CABG (2009 to 2020) who did not receive oral anticoagulation at discharge, mirroring the therapeutic dilemma a clinician faces at discharge.
The four-item PRECISE-DAPT score (age, creatinine clearance, preoperative haemoglobin, previous bleeding) classified 36% of the patients as high risk.
Major bleeding during the first year occurred in 0.8% of low-risk, 1.9% of moderate-risk and 3.6% of high-risk patients, with a hazard ratio of 4.81 (95% CI 2.59 to 8.96) for high versus low risk.Discrimination was moderate (AUC 0.68) and calibration was good up to a predicted annual risk of about 7%.
This is an observational registry study. Patients on anticoagulation were excluded, so the findings apply to those judged safe to discharge without it, and registry-based definitions will miss bleeds that did not lead to hospitalisation. The score separates risk groups, but whether using it to guide anticoagulation improves outcomes will need prospective, randomized testing.”
Title: Bleeding risk assessment in patients with new-onset atrial fibrillation after coronary surgery: a proof-of-concept study
Authors: Mary Rezk, Amar Taha, Andreas Martinsson, Susanne J Nielsen, Tomas Gudbjartsson, Lennart Bergfeldt, Florian E M Herrmann, Emma C Hansson, Anders Jeppsson

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 23:18Claire Hills: New Paper on Immune Surveillance and Immune Evasion of Senescent Cells
-
Aug 14, 2026, 23:16Are We Overlooking What Matters Most to Women with Von Willebrand Disease? – RPTH Journal
-
Aug 14, 2026, 23:15Markus Müller: A New Base Editing Approach Targeting PCSK9 to Lower Cholesterol Levels
-
Aug 14, 2026, 23:14Chokri Ben Lamine: Avatrombopag in Hematology – Dosing and Monitoring
-
Aug 14, 2026, 19:04Ravi Kumar: Why Lupus Anticoagulant Predicts Clots, Not Bleeding
-
Aug 14, 2026, 18:53Veli Bakalov: The Number Every Hematologist Should Know in Polycythemia Vera
-
Aug 14, 2026, 18:41Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight
-
Aug 14, 2026, 18:20Venkata Sagi: Systemic Anticoagulation or Left Atrial Appendage Closure?